Bacteremia in patients with febrile neutropenia following chemotherapy (original) (raw)
Management of febrile neutropenia: A description of clinical and microbiological findings by focusing on risk factors and pitfalls
Azadeh Moghaddas
Journal of Research in Pharmacy Practice
View PDFchevron_right
Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India
Vinod Raina
Medical Oncology, 2011
View PDFchevron_right
Response of First-Line Antibiotic Therapy in Patients with Febrile Neutropenia During Treatment of Hematological Disorders
T. Farzana
Indian Journal of Hematology and Blood Transfusion, 2014
View PDFchevron_right
A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer Chemotherapy
Thomas Walsh
New England Journal of Medicine, 1999
View PDFchevron_right
Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients
rachan shetty
Journal of Laboratory Physicians, 2015
View PDFchevron_right
Evaluation of Risk Factors for Mortality in Febrile Neutropenia
Habip Gedik
The Journal of Infection in Developing Countries, 2020
View PDFchevron_right
Evaluation of Bloodstream Infections During Chemo- Therapy-Induced Febrile Neutropenia in Patients with Malignant Hematological Diseases: Single Center Experience
Flóra Tímár
2015
View PDFchevron_right
Febrile Neutropenia in Haematological Disorders: a Single Centre review of Antibiotic Policy and the Outcome
T. Farzana
2003
View PDFchevron_right
The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies
Eva Johansson
Haematologica, 2006
View PDFchevron_right
The spectrum of bacterial infections in febrile neutropenic patients. The effect on empiric antibiotic therapy
Ikram Burney
Journal of the Pakistan Medical Association
View PDFchevron_right
Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country
Razan Odeh, Riad Amer
View PDFchevron_right
Results of high-risk neutropenia therapy of hematology-oncology patients in a university hospital in Uruguay
Regina Guadagna
Revista brasileira de hematologia e hemoterapia
View PDFchevron_right
The spectrum of bacterial infections in febrile neutropenic patients: effect on empiric antibiotic therapy
Ikram Burney
PubMed, 1998
View PDFchevron_right
Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment
Hakon Reikvam
Mediterranean Journal of Hematology and Infectious Diseases, 2019
View PDFchevron_right
Interventional antimicrobial therapy in febrile neutropenic patients
Peter Meyer
Annals of Hematology, 1994
View PDFchevron_right
Management of the febrile neutropenic patient in 2023
Oana-Alexandra Ganea
Romanian Journal of Infectious Diseases
View PDFchevron_right
Variation in Antimicrobial Utilization for Febrile Neutropenia in Cancer Patients
T. Szucs
Infection, 2000
View PDFchevron_right
Clinical and Microbiological Profile of Pathogens in Febrile Neutropenia in Hematological Malignancies: A Single Center Prospective Analysis
Sidra Maqsood
View PDFchevron_right
A Randomized, Prospective Open Labeled Study of Oral Amoxicillin-clavulanate and Levofloxacin with Intravenous Ceftriaxone and Amikacin in Chemotherapy Induced Low Risk Febrile Neutropenia
Sreenivas Vishnubhatla
View PDFchevron_right
The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit
Gerry Hobbs
Bone Marrow Transplantation, 2007
View PDFchevron_right
Clinical impact of cycling the administration of antibiotics for febrile neutropenia in Japanese patients with hematological malignancy
Takeshi Kondo
European Journal of Clinical Microbiology & Infectious Diseases, 2011
View PDFchevron_right
Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases
Theis Aagaard
Open forum infectious diseases, 2018
View PDFchevron_right
clinical practice guidelines Management of febrile neutropenia: ESMO Clinical Practice Guidelines On behalf of the ESMO Guidelines Working Group
riti arora
View PDFchevron_right
Epidemiology of Febrile Neutropenia
Gary Lyman
Supportive Cancer Therapy, 2003
View PDFchevron_right
Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia
Sergio Mecarocci, Caterina Stefanizzi
Annals of Hematology, 2007
View PDFchevron_right
Infection pattern of neutropenic patients in post-chemotherapy phase of acute leukemia treatment
Ahmad Ahmadzadeh
Hematology Reports, 2013
View PDFchevron_right
Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity
Yong Chong
PLoS ONE, 2013
View PDFchevron_right
Bacteremia Pattern in Febrile Neutropenia among Adults Cancer Patients Receiving Chemotherapy in an Australia Regional Hospital
Tunde Ibrahim
Universal journal of public health, 2017
View PDFchevron_right
Outcomes of High Risk Patients with Febrile Neutropenia at a Tertiary Care Center
BILAL HASSAN
Asian Pacific journal of cancer prevention : APJCP, 2017
View PDFchevron_right
Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia
Furuzan Kokturk
Journal of Geriatric Oncology, 2013
View PDFchevron_right